Astrazeneca AZN
NYSE AZN
$160.15 +0.51 (+0.32%)
As of: Sep 11, 2026 · 3:59 PM EDT

Astrazeneca (AZN) EBT Growth (3y) (2012 - 2026)

Analysis

Astrazeneca (AZN) EBT Growth (3y) (2012 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Growth (3y) (Qtr)
1 Asml Holding 659.69 Bn 643.71 Bn 5.90 Bn -
2 General Electric 337.12 Bn 327.78 Bn 6.95 Bn 22.90%
3 Astrazeneca 247.89 Bn 242.60 Bn 12.86 Bn 10.26%
4 Citigroup 236.49 Bn -2,065.81 Bn 24.75 Bn -
5 Bhp 220.99 Bn 202.45 Bn - -
6 Rio Tinto 206.31 Bn 201.93 Bn - -
7 Diageo 192.64 Bn 190.61 Bn - -
8 National Grid 165.59 Bn 161.82 Bn - -
9 Unilever 135.28 Bn 128.25 Bn - -
10 Hdfc Bank 119.43 Bn 82.28 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 10.26%
Mar 31, 2026 20.05%
Dec 31, 2025 162.68%
Sep 30, 2025 52.10%
Jun 30, 2025 133.06%
Mar 31, 2025 83.23%
Dec 31, 2024 66.54%
Sep 30, 2024 42.83%
Jun 30, 2024 46.39%
Mar 31, 2024 20.31%
Dec 31, 2023 72.61%
Sep 30, 2023 24.65%
Jun 30, 2023 29.52%
Mar 31, 2023 34.24%
Dec 31, 2022 48.00%
Sep 30, 2022 31.12%
Jun 30, 2022 20.55%
Mar 31, 2022 -9.98%
Dec 31, 2021 -42.13%
Sep 30, 2021 -83.66%